ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Fate Therapeutics (FATE)

Technical Analysis Report for NASDAQ stock FATE Fate Therapeutics. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock FATE Fate Therapeutics then click here. or read Experts views on Fate Therapeutics or Forecast & share price targets of Fate Therapeutics

Fate Therapeutics Opened at 1.06 and Closed at: 1.14, which is 7.89% of previous session's close. It moved within a range of 1.05 and 1.14
The session was a Bullish session with an average volume of 1501300, which is -16.55% of previous session's volumes.

    Support for tomorrow is 1.1 and resistance for tomorrow is 1.19
    These support and resistance points are valid for the first 5-15 minutes charts

    Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

    Support for tomorrow's hourly charts is 1.08, 1.02 resistance for tomorrow's hourly charts is 1.17, 1.2

    10 Day SMA for Fate Therapeutics (FATE) is 1.19 and stock is trading below these levels. This is not a good sign for its short term trend

    20 Day SMA for Fate Therapeutics (FATE) is 1.15 and the stock is trading below these levels. This is not a good sign for its mid term trend

    50 Day SMA for Fate Therapeutics (FATE) is 1.09 and the stock is trading above these levels. This is a good sign for its mid to long term trend

    100 Day SMA is 1.16 and the stock is trading below these levels. This is not a good sign for its long term trend

    200 Day SMA Fate Therapeutics is 1.16 and stock is trading below these levels. This is not a good sign for its long term trend

    20 DMA of Fate Therapeutics is at 1.15 and 200 DMA is at 1.16, while 50 DMA and 100 DMA are at 1.09 and 1.16 respectively

    Fate Therapeutics (FATE) moving average of 20 SMA is at 1.15 and 20 EMA is at 1.14

    Fate Therapeutics (FATE) moving average of 50 SMA is at 1.09 and 50 EMA is at 1.12

    Fate Therapeutics (FATE) moving average of 100 SMA is at 1.16 and 100 EMA is at 1.23

    Fate Therapeutics (FATE) moving average of 200 SMA is at 1.16 and 200 EMA is at 1.46

    Fate Therapeutics has performed better than Vanda Pharmaceuticals in short term. Holding Fate Therapeutics could be a better choice for now!

    Scynexis Inc has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Scynexis Inc, about 4.86% more returns!

    Fate Therapeutics has performed better than Rhythm Pharmaceuticals in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Riot Blockchain in short term. Holding Fate Therapeutics could be a better choice for now!

    Moleculin Biotech has performed better than Fate Therapeutics in short term. You could have earned much better returns by investing in Moleculin Biotech, about 1.1% more returns!

    Fate Therapeutics has performed better than Microbot Medical in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Lipocine Inc in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Acadia Pharmaceuticals in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Acadia Healthcare in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Achieve Life in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Apellis Pharmaceuticals in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Accuray Incorporated in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Arrowhead Pharmaceuticals in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Cocrystal Pharma in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Catalyst Pharmaceuticals in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Electrocore Inc in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Fortress Biotech in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Galmed Pharmaceuticals in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics has performed better than Hoth Therapeutics in short term. Holding Fate Therapeutics could be a better choice for now!

    Fate Therapeutics Technical analysis of indicators

    Price action analysis of Fate Therapeutics (FATE) based on a short term time period is neutral. A longer time frame might give a better analysis.

    ADX buy sell signal for Fate Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

    MACD generated a SELL signal for Fate Therapeutics in short term but the sell signal is initial and weak.

    Fate Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!

    Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up

    CCI has generated a buy signal for Fate Therapeutics in short term but BUY signal is weak.

    RSI is generating a BUY signal in short term and the buying is gaining momentum.

    MRSI is in positive zone. This is a BUY zone

    Stock of Fate Therapeutics is picking up buying momentum according to indicator.

    Volume based indicators are showing selling momentum.

    Volume Weighted Averaged Price (VWAP) for short term is 1.19 and Fate Therapeutics FATE stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down

    People seem to be coming out and selling the Fate Therapeutics FATE stock. Volume based technical analysis of Fate Therapeutics FATE stock is negative.

    Fate Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive

    Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

    Tomorrow's Predictions

    You should also read Tomorrow's Movement Predictions for NASDAQ stock FATE Fate Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

    And FATE Experts View which covers a lot of information including buying and selling signals

    FATE future forecast & share price targets

    You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Fate Therapeutics or View Candle Stick Charts here

    Chart Fate Therapeutics (FATE)  Technical (Analysis) Reports Fate Therapeutics [

    Videos related to: Fate Therapeutics (FATE) Technical (Analysis) Reports Fate Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

    Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

    Hindi Video Most Important Stock Market Video. No Success Without This Formula

    Fate Therapeutics (FATE)  Technical (Analysis) Reports Fate Therapeutics [

     

    Back to top